Skip Navigation

JNCI Journal of the National Cancer Institute 1990 82(9):772-776; doi:10.1093/jnci/82.9.772
© 1990 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kilbourn, R. G.
Right arrow Articles by Belloni, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilbourn, R. G.
Right arrow Articles by Belloni, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 82, No. 9, 772-776, May 2, 1990
© 1990 Oxford University Press

Endothelial Cell Production of Nitrogen Oxides in Response to Interferon {gamma} in Combination With Tumor Necrosis Factor, Interleukin-1, or Endotoxin

Robert G. Kilbourn*, Paula Belloni

Department of Medical Oncology, Genitourinary Section,The University of Texas M. D. Anderson Cancer Center Houston, TX
Department of Tumor Biology,The University of Texas M. D. Anderson Cancer Center Houston, TX

*Correspondence to: Robert G. Kilboum, Ph.D., Department of Medical Oncology, Genitourinary Section, The University of Texas M. D. Anderson Cancer Center, Box 13, 1515 Holcombe Blvd., Houston, TX 77030.

Clinical studies using biological response modifiers in cancer therapy have shown that the major dose-limiting toxic effects are hypotension and diffuse microvascular leakage. The cause and pathophysiology of this hypotension remains unknown. Previous experiments have demonstrated that a number of cell types, including endothelial cells, neu-trophils, and macrophages, can secrete a potent hypotensive agent—endothelium-derived relaxing factor, which has recently been identified as nitric oxide. In this study, we tested interferon {gamma}, tumor necrosis factor, interleukin-1, in-terleukin-2, muramyl dipeptide, and endotoxin for their effects on production of nitrogen oxides by endothelial cells. Interferon y, in combination with tumor necrosis factor, interleukin-1 (IL-1), or endotoxin, induced murine brain endothelial cells to secrete nitrites (20–45 µM within 48 hr), which are breakdown products of nitric oxide. Nitrite production was blocked by incubation of endotheliai cells in medium without L-arginine, a substrate for nitric-oxide synthase. Accumulation of nitrites was also inhibited by addition of NG-monomethyl-L-arginine (l-NMMA), which acts as a competitive inhibitor of this enzyme. The inhibitory effects of l-NMMA were reversed by addition of excess L-arginine. These results suggest (a) that endothelial cells produce nitric oxide in response to immunomod-ulators and (b) that endothelial cell-derived nitric oxide plays a role in the development of hypotension in patients treated with tumor necrosis factor or interleukins. Furthermore, administration of substrate analogues such as l-NMMA may favorably alter the toxicity associated with these immunomodulators and result in a higher maximum tolerated dose, with subsequent improvement in the antitumor activity. J Natl Cancer Inst 82: 772–brief-report776, 1990]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. J. Kim, K. Tsoyi, J. M. Heo, Y. J. Kang, M. K. Park, Y. S. Lee, J. H. Lee, H. G. Seo, H. S. Yun-Choi, and K. C. Chang
Regulation of Lipopolysaccharide-Induced Inducible Nitric-Oxide Synthase Expression through the Nuclear Factor-{kappa}B Pathway and Interferon-beta/Tyrosine Kinase 2/Janus Tyrosine Kinase 2-Signal Transducer and Activator of Transcription-1 Signaling Cascades by 2-Naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a New Synthetic Isoquinoline Alkaloid
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 782 - 789.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Takeda, H Watanabe, T Saito, K Saito, H Takeda, H Togashi, J Fujii, Y Takasago, and S Kawata
Impaired portal circulation resulting from L-arginine deficiency in patients with lysinuric protein intolerance.
Gut, October 1, 2006; 55(10): 1526 - 1527.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L.-Q. Qiu, R. Sinniah, and S. I-H. Hsu
Coupled Induction of iNOS and p53 Upregulation in Renal Resident Cells May Be Linked with Apoptotic Activity in the Pathogenesis of Progressive IgA Nephropathy
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2066 - 2078.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
I. A. Clark, L. M. Alleva, A. C. Mills, and W. B. Cowden
Pathogenesis of Malaria and Clinically Similar Conditions
Clin. Microbiol. Rev., July 1, 2004; 17(3): 509 - 539.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. L. Cummings and R. L. Tarleton
Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice
Infect. Immun., July 1, 2004; 72(7): 4081 - 4089.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. M. K. Boje, D. Jaworowicz Jr., and J. J. Raybon
Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. C. Schiltz and P. E. Sawchenko
Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults
J. Neurosci., July 1, 2002; 22(13): 5606 - 5618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Kleschyov, B. Muller, T. Keravis, M.-E. Stoeckel, and J.-C. Stoclet
Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2743 - H2751.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Morikawa, N. Koide, Y. Kato, T. Sugiyama, D. Chakravortty, T. Yoshida, and T. Yokochi
Augmentation of Nitric Oxide Production by Gamma Interferon in a Mouse Vascular Endothelial Cell Line and Its Modulation by Tumor Necrosis Factor Alpha and Lipopolysaccharide
Infect. Immun., November 1, 2000; 68(11): 6209 - 6214.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Xu, L. He, S. H. Ahmed, S.-W. Chen, M. P. Goldberg, J. S. Beckman, C. Y. Hsu, and C. Iadecola
Oxygen-Glucose Deprivation Induces Inducible Nitric Oxide Synthase and Nitrotyrosine Expression in Cerebral Endothelial Cells Editorial Comment
Stroke, July 1, 2000; 31(7): 1744 - 1751.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Comini, T. Bachetti, L. Agnoletti, G. Gaia, S. Curello, B. Milanesi, M. Volterrani, G. Parrinello, C. Ceconi, A. Giordano, et al.
Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-{alpha}
Eur. Heart J., October 2, 1999; 20(20): 1503 - 1513.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. V. Suschek, V. Krischel, D. Bruch-Gerharz, D. Berendji, J. Krutmann, K.-D. Kroncke, and V. Kolb-Bachofen
Nitric Oxide Fully Protects against UVA-induced Apoptosis in Tight Correlation with Bcl-2 Up-regulation
J. Biol. Chem., March 5, 1999; 274(10): 6130 - 6137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. J. BJERTNAES, T. KOIZUMI, and J. H. NEWMAN
Inhaled Nitric Oxide Reduces Lung Fluid Filtration after Endotoxin in Awake Sheep
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Suto, A. Mikuniya, T. Okubo, H. Hanada, N. Shinozaki, and K. Okumura
Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H41 - H49.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Okamoto, O. Ito, R. J. Roman, A. G. Hudetz, and R. M. Bryan Jr
Role of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Endotoxin-Induced Cerebral Hyperemia • Editorial Comment
Stroke, June 1, 1998; 29(6): 1209 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
N. Smail, R. A. Catania, P. Wang, W. G. Cioffi, K. I. Bland, and I. H. Chaudry
Gut and Liver: The Organs Responsible for Increased Nitric Oxide Production After Trauma-Hemorrhage and Resuscitation
Arch Surg, April 1, 1998; 133(4): 399 - 405.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Yap, T. Scharton-Kersten, H. Charest, and A. Sher
Decreased Resistance of TNF Receptor p55- and p75-Deficient Mice to Chronic Toxoplasmosis Despite Normal Activation of Inducible Nitric Oxide Synthase In Vivo
J. Immunol., February 1, 1998; 160(3): 1340 - 1345.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. M. FARACI and D. D. HEISTAD
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
Physiol Rev, January 1, 1998; 78(1): 53 - 97.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Kessler, J. Bauersachs, R. Busse, and V. B. Schini-Kerth
Inhibition of Inducible Nitric Oxide Synthase Restores Endothelium-Dependent Relaxations in Proinflammatory Mediator-Induced Blood Vessels
Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1746 - 1755.
[Abstract] [Full Text]


Home page
HypertensionHome page
K.-F. Lin, L. Chao, and J. Chao
Prolonged Reduction of High Blood Pressure With Human Nitric Oxide Synthase Gene Delivery
Hypertension, September 1, 1997; 30(3): 307 - 313.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. N. A. Hussain, A. Giaid, Q. E. Dawiri, D. Sakkal, R. Hattori, and Y. Guo
Expression of Nitric Oxide Synthases and GTP Cyclohydrolase I in the Ventilatory and Limb Muscles During Endotoxemia
Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 173 - 180.
[Abstract] [Full Text]


Home page
BloodHome page
J. W. Lee, C. Beckham, B. R. Michel, H. Rosen, and H. J. Deeg
HLA-DR-Mediated Signals for Hematopoiesis and Induction of Apoptosis Involve But Are Not Limited to a Nitric Oxide Pathway
Blood, July 1, 1997; 90(1): 217 - 225.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. B. Schini-Kerth, M. Boese, R. Busse, B. Fisslthaler, and A. Mulsch
N-{alpha}-Tosyl-L-Lysine Chloromethylketone Prevents Expression of iNOS in Vascular Smooth Muscle by Blocking Activation of NF-{kappa}B
Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 672 - 679.
[Abstract] [Full Text]


Home page
Arch. Dis. Child.Home page
T. Duke, M. South, and A. Stewart
Activation of the L-arginine nitric oxide pathway in severe sepsis
Arch. Dis. Child., March 1, 1997; 76(3): 203 - 209.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. A. Arnet, A. McMillan, J. L. Dinerman, B. Ballermann, and C. J. Lowenstein
Regulation of Endothelial Nitric-oxide Synthase during Hypoxia
J. Biol. Chem., June 21, 1996; 271(25): 15069 - 15073.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Durante, L. Liao, I. Iftikhar, W. E. O'Brien, and A. I. Schafer
Differential Regulation of L-Arginine Transport and Nitric Oxide Production by Vascular Smooth Muscle and Endothelium
Circ. Res., June 1, 1996; 78(6): 1075 - 1082.
[Abstract] [Full Text]


Home page
Innate ImmunityHome page
M. Burnier and G. Centeno
Escherichia coli endotoxin increases cytosolic free Ca2+ by mobilizing intracellular calcium stores in cultured endothelial cells
Innate Immunity, April 1, 1996; 3(2): 119 - 127.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
M.J. Parmely, S.-Y. Hao, D.C. Morrison, and J.L. Pace
Role of macrophage-derived nitric oxide in endotoxin lethality in mice
Innate Immunity, February 1, 1995; 2(1): 45 - 52.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.